nav-left cat-right
cat-right

UCSF, Stanford and Johns Hopkins join FDA partners...

At a time when Big Pharma is increasingly tapping academic institutions for expertise in informatics and data-driven computer models for drug discovery, the FDA has selected Johns Hopkins University, Stanford University and the University of California, San Francisco (UCSF) for a new initiative aimed at streamlining the drug development and approval process. Under the FDA’s Centers of Excellence in Regulatory Science...

Gates, Wellcome bet $40M on Kymab’s antibody...

Cambridge, U.K.’s Kymab touts its drug development platform as an ideal way to spotlight new antibodies, and some bright minds would seem to agree, as the Wellcome Trust and Bill and Melinda Gates Foundation have teamed up on a $40 million round for the biotech. Under the Series B terms, each organization will hand over $20 million to support the company’s Kymouse technology, a genetically engineered mouse...

Seattle BioMed receives $10M NIAID grant to lead A...

The National Institute of Allergy and Infectious Diseases has awarded a 7-year, $9.8 million grant to develop an AIDS vaccine to four Seattle-based research organizations and Rockefeller University. The nonprofit Seattle Biomedical Research Institute will lead the research team, which will be made up of researchers from the University of Washington, Fred Hutchinson Cancer Research Center, Seattle Children’s Hospital and...

UK “breakthrough” drug program

Impressed by the success of the FDA’s breakthrough therapy designation, U.K. regulators are considering a similar effort to speed the path for promising drugs, according to an industry group. The nation’s government is in the midst of “active discussion across Whitehall” on a plan that would fast-track certain treatments, according to the trade group U.K. BioIndustry Association. Under the proposal,...

AstraZeneca, Bristol-Myers grant for diabetes rese...

AstraZeneca’s ($AZN) and Bristol-Myers Squibb’s ($BMY) U.S. Diabetes Alliance is giving a three-year, $5 million grant to the American Diabetes Association’s Pathway to Stop Diabetes program. The Pathway initiative provides up to $1.6 million in support for 5 to 7 years to selected investigators to help fund research relevant to any diabetes type, diabetes-related disease state or diabetes...

The NCI is offering $20M to projects that move can...

The National Cancer Institute (NCI) faces a growing data problem. As the scale of its projects grows–one initiative is expected to generate 2.5 petabytes of data–downloading results for analysis on local systems becomes impractical. Recognizing this, the NCI has allocated $20 million for cloud-based genomics pilot projects. Having spent last year gathering feedback on what users want from cloud-based cancer...
Page 1 of 912345...Last »